Study finds the condition can develop after COVID-19 in patients lacking predisposing conditions, but cases are rare and visual outcomes are good.
Multidisciplinary clinic brings specialists together in one setting for improved patient access.
New techniques are eradicating tumors and preserving vision for pediatric patients with retinoblastoma.
A cytokine that acts as an antioxidant proves neuroprotective against ocular injury.
New studies explore advances in standard and immunosuppressive therapies.
Clinical trial results suggest new therapies could restore vision lost to LHON.
Monoclonal antibody is promising treatment for disabling autoimmune disorder.
1 / 5
Our ophthalmology experts showcase their latest advances in research and clinical care.
New studies take crucial steps toward transplanting retinal ganglion cells.
Team identifies gene variants causing a disabling form of generalized autonomic failure.